Amgen Inc. (AMGN)
NASDAQ · Health Care · market cap 181.77B
Share price
$465.45
At the last nightly close
Intrinsic value
$289.09
Range $289.09 – $399.42 — the conservative figure is the low end.
Margin of safety
-37.9%
($289.09 − $465.45) ÷ $465.45
EV / EBIT
35.1
On the median operating profit of 15 fiscal years through 2025.
How these numbers are computed
The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above starts from the lower of the first two; the Graham Number never enters it.
The frame gives no credit for growth unless the company has earned it: only a return on invested capital that has beaten the cost of capital year after year earns a growth credit, and that credit is capped. A company that compounds will therefore usually read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.
The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.
Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-10-16.
Key metrics
Market position
Annual financials
| Period | Revenue | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|
| 2025-FY | 36.75B | 9.08B | 7.71B | 14.33 | 8.10B |
| 2024-FY | 33.42B | 7.26B | 4.09B | 7.62 | 10.39B |
| 2023-FY | 28.19B | 7.90B | 6.72B | 12.56 | 7.36B |
| 2022-FY | 26.32B | 9.57B | 6.55B | 12.18 | 8.79B |
| 2021-FY | 25.98B | 7.64B | 5.89B | 10.28 | 8.38B |
Filed figures from SEC EDGAR, in the reporting currency.
Next earnings
Recent news
- Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Buildtradingkey.com
- Why Amgen (AMGN) Stock Is Trading Up Today - StockStorystockstory.org
- Amgen Stock Erased a 17% Drawdown. A MariTide Switch Study Explains Why. | TIKR.comtikr.com
- Amgen Inc. (AMGN) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com
- AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTSprnewswire.com
Headlines link to their source. Sperio does not republish article text.
The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on AMGN.
Run the board on AMGN10 free analyses · no signup, no card
This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.